Lozilurea
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171948This classification denotes an anti-ulcer agent with the molecular formula C10H13ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 677AYV0R9N, chemically known as urea, n-(m-chlorobenzyl)-n-ethyl- but generally known as lozilurea, which bears US NIH Compound Identifier 68907. European Medicines Agency schedules Lozilurea in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08611MIG. The term LOZILUREA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). LOZILUREA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lozilurea under HS 29242190 and SITC 51473. As of Q4 2014, LOZILUREA remains the US FDA Preferred Term for this commodity. Lozilurea bears US NLM identifiers UMLS ID C0620245 and NCI Concept Code C66039. SMILES: CCNC(=O)NCC1=CC(=CC=C1)CL.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.